Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$572M |
| 2 |
Sherwin-Williams
SHW
|
+$570M |
| 3 |
Amazon
AMZN
|
+$440M |
| 4 |
NXP Semiconductors
NXPI
|
+$346M |
| 5 |
International Flavors & Fragrances
IFF
|
+$334M |
Top Sells
| 1 |
DuPont de Nemours
DD
|
+$222M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$186M |
| 3 |
Booking.com
BKNG
|
+$122M |
| 4 |
EV
Eaton Vance Corp.
EV
|
+$104M |
| 5 |
iShares MSCI Taiwan ETF
EWT
|
+$80.1M |
Sector Composition
| 1 | Technology | 23.28% |
| 2 | Financials | 13.75% |
| 3 | Healthcare | 13.2% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Communication Services | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
2151
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $13.3M | ﹤0.01% |
458,313
+112,796
| +33% | +$3.28M |
|
2152
RB Global
RBA
$21.7B
| $13.3M | ﹤0.01% |
227,969
+21,698
| +11% | +$1.27M |
|
|
ABTX
2153
DELISTED
Allegiance Bancshares, Inc.
ABTX
| $13.3M | ﹤0.01% |
328,172
+22,329
| +7% | +$905K |
|
2154
Organogenesis Holdings
ORGO
$625M
| $13.3M | ﹤0.01% |
730,112
+14,660
| +2% | +$267K |
|
2155
Donnelley Financial Solutions
DFIN
$1.5B
| $13.3M | ﹤0.01% |
476,790
+37,066
| +8% | +$1.03M |
|
2156
Rhythm Pharmaceuticals
RYTM
$6.39B
| $13.3M | ﹤0.01% |
623,562
+135,115
| +28% | +$2.87M |
|
|
GTHX
2157
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $13.3M | ﹤0.01% |
551,183
+67,343
| +14% | +$1.62M |
|
2158
Caleres
CAL
$503M
| $13.2M | ﹤0.01% |
607,790
+62,055
| +11% | +$1.35M |
|
2159
Weis Markets
WMK
$1.75B
| $13.2M | ﹤0.01% |
234,046
+21,398
| +10% | +$1.21M |
|
2160
Cameco
CCJ
$34B
| $13.2M | ﹤0.01% |
803,331
+65,326
| +9% | +$1.07M |
|
2161
Varex Imaging
VREX
$469M
| $13.2M | ﹤0.01% |
644,464
+60,071
| +10% | +$1.23M |
|
2162
Replimune Group
REPL
$447M
| $13.2M | ﹤0.01% |
431,929
+51,037
| +13% | +$1.56M |
|
|
CNST
2163
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $13.1M | ﹤0.01% |
561,845
+63,637
| +13% | +$1.49M |
|
2164
OptimizeRx
OPRX
$322M
| $13.1M | ﹤0.01% |
269,492
+38,832
| +17% | +$1.89M |
|
2165
Horizon Bancorp
HBNC
$833M
| $13.1M | ﹤0.01% |
705,912
+59,868
| +9% | +$1.11M |
|
2166
Sanofi
SNY
$115B
| $13.1M | ﹤0.01% |
264,775
+7,681
| +3% | +$380K |
|
2167
Kelly Services Class A
KELYA
$481M
| $13.1M | ﹤0.01% |
586,350
+59,722
| +11% | +$1.33M |
|
2168
Great Southern Bancorp
GSBC
$710M
| $13.1M | ﹤0.01% |
230,386
+13,173
| +6% | +$746K |
|
2169
HarborOne Bancorp
HONE
$563M
| $13M | ﹤0.01% |
967,568
+58,308
| +6% | +$785K |
|
2170
Ribbon Communications
RBBN
$676M
| $13M | ﹤0.01% |
1,582,892
+146,231
| +10% | +$1.2M |
|
|
FBMS
2171
DELISTED
The First Bancshares, Inc.
FBMS
| $13M | ﹤0.01% |
353,835
+28,043
| +9% | +$1.03M |
|
|
SRG
2172
Seritage Growth Properties
SRG
$237M
| $12.9M | ﹤0.01% |
704,424
+42,564
| +6% | +$781K |
|
|
MGP
2173
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $12.9M | ﹤0.01% |
396,179
+52,123
| +15% | +$1.7M |
|
2174
Helix Energy Solutions
HLX
$914M
| $12.9M | ﹤0.01% |
2,557,108
+247,032
| +11% | +$1.25M |
|
2175
Sutro Biopharma
STRO
$74.3M
| $12.9M | ﹤0.01% |
566,649
+148,130
| +35% | +$3.37M |
|